Literature DB >> 18281487

Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer.

Kentaro Iwanaga1, Yanan Yang, Maria Gabriela Raso, Lijiang Ma, Amy E Hanna, Nishan Thilaganathan, Seyed Moghaddam, Christopher M Evans, Huaiguang Li, Wei-Wen Cai, Mitsuo Sato, John D Minna, Hong Wu, Chad J Creighton, Francesco J Demayo, Ignacio I Wistuba, Jonathan M Kurie.   

Abstract

Phosphatase and tensin homologue deleted from chromosome 10 (Pten) is expressed aberrantly in non-small cell lung cancer cells, but the role of Pten in lung neoplasia has not been fully elucidated. In this study, we used a genetic approach to inactivate Pten in the bronchial epithelium of mice. Although, by itself, Pten inactivation had no discernible effect on bronchial epithelial histology, it accelerated lung tumorigenesis initiated by oncogenic K-ras, causing more rapid lethality than that induced by oncogenic K-ras alone (8 weeks versus 24 weeks of median duration of survival, respectively). Lung tumors arose in K-ras mutant, Pten-deficient mice that rapidly obstructed bronchial lumina and replaced alveolar spaces. Relative to K-ras mutant tumors, the K-ras mutant, Pten-deficient tumors exhibited more advanced histologic severity and more prominent inflammation and vascularity. Thus, Pten inactivation cooperated with oncogenic K-ras in promoting lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281487      PMCID: PMC2750029          DOI: 10.1158/0008-5472.CAN-07-3117

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects.

Authors:  David A Tuveson; Alice T Shaw; Nicholas A Willis; Daniel P Silver; Erica L Jackson; Sandy Chang; Kim L Mercer; Rebecca Grochow; Hanno Hock; Denise Crowley; Sunil R Hingorani; Tal Zaks; Catrina King; Michael A Jacobetz; Lifu Wang; Roderick T Bronson; Stuart H Orkin; Ronald A DePinho; Tyler Jacks
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

2.  Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Authors:  Jean-Charles Soria; Ho-Young Lee; Janet I Lee; Luo Wang; Jean-Pierre Issa; Bonnie L Kemp; Diane D Liu; Jonathan M Kurie; Li Mao; Fadlo R Khuri
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

3.  Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.

Authors:  T Mitsudomi; J Viallet; J L Mulshine; R I Linnoila; J D Minna; A F Gazdar
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

4.  Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

Authors:  D A Arenberg; S L Kunkel; P J Polverini; M Glass; M D Burdick; R M Strieter
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death.

Authors:  Marie Wislez; Nathalie Rabbe; Joëlle Marchal; Bernard Milleron; Bruno Crestani; Charles Mayaud; Martine Antoine; Paul Soler; Jacques Cadranel
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

Review 6.  PTEN: one gene, many syndromes.

Authors:  Charis Eng
Journal:  Hum Mutat       Date:  2003-09       Impact factor: 4.878

Review 7.  Classification of proliferative pulmonary lesions of the mouse: recommendations of the mouse models of human cancers consortium.

Authors:  Alexander Yu Nikitin; Ana Alcaraz; Miriam R Anver; Roderick T Bronson; Robert D Cardiff; Darlene Dixon; Armando E Fraire; Edward W Gabrielson; William T Gunning; Diana C Haines; Matthew H Kaufman; R Ilona Linnoila; Robert R Maronpot; Alan S Rabson; Robert L Reddick; Sabine Rehm; Nora Rozengurt; Hildegard M Schuller; Elena N Shmidt; William D Travis; Jerrold M Ward; Tyler Jacks
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

8.  Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression.

Authors:  Jian-Hua Mao; Minh D To; Jesus Perez-Losada; Di Wu; Reyno Del Rosario; Allan Balmain
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

9.  Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.

Authors:  Carmen Guerra; Nieves Mijimolle; Alma Dhawahir; Pierre Dubus; Marta Barradas; Manuel Serrano; Victoria Campuzano; Mariano Barbacid
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

10.  Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.

Authors:  M Mori; F Tezuka; R Chiba; Y Funae; M Watanabe; T Nukiwa; T Takahashi
Journal:  Cancer       Date:  1996-02-15       Impact factor: 6.860

View more
  62 in total

1.  Persistent ERK/MAPK activation promotes lactotrope differentiation and diminishes tumorigenic phenotype.

Authors:  Allyson Booth; Tammy Trudeau; Crystal Gomez; M Scott Lucia; Arthur Gutierrez-Hartmann
Journal:  Mol Endocrinol       Date:  2014-12

2.  Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors.

Authors:  Julian Carretero; Takeshi Shimamura; Klarisa Rikova; Autumn L Jackson; Matthew D Wilkerson; Christa L Borgman; Matthew S Buttarazzi; Benjamin A Sanofsky; Kate L McNamara; Kathleyn A Brandstetter; Zandra E Walton; Ting-Lei Gu; Jeffrey C Silva; Katherine Crosby; Geoffrey I Shapiro; Sauveur-Michel Maira; Hongbin Ji; Diego H Castrillon; Carla F Kim; Carlos García-Echeverría; Nabeel Bardeesy; Norman E Sharpless; Neil D Hayes; William Y Kim; Jeffrey A Engelman; Kwok-Kin Wong
Journal:  Cancer Cell       Date:  2010-06-15       Impact factor: 31.743

3.  MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.

Authors:  Lixia Guo; Jingyu Wang; Ping Yang; Qiang Lu; Ting Zhang; Yanan Yang
Journal:  IUBMB Life       Date:  2015-08-27       Impact factor: 3.885

4.  A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration.

Authors:  Yuzhen Zhang; Ashley M Goss; Ethan David Cohen; Rachel Kadzik; John J Lepore; Karthika Muthukumaraswamy; Jifu Yang; Francesco J DeMayo; Jeffrey A Whitsett; Michael S Parmacek; Edward E Morrisey
Journal:  Nat Genet       Date:  2008-06-08       Impact factor: 38.330

5.  ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.

Authors:  Yanan Yang; Young-Ho Ahn; Yulong Chen; Xiaochao Tan; Lixia Guo; Don L Gibbons; Christin Ungewiss; David H Peng; Xin Liu; Steven H Lin; Nishan Thilaganathan; Ignacio I Wistuba; Jaime Rodriguez-Canales; Georgia McLendon; Chad J Creighton; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

6.  Expression of PPARγ and PTEN in human colorectal cancer: An immunohistochemical study using tissue microarray methodology.

Authors:  Mao Song Lin; Jun Xing Huang; Wei Chang Chen; Bao Feng Zhang; Jing Fang; Qiong Zhou; Ying Hu; Heng Jun Gao
Journal:  Oncol Lett       Date:  2011-09-06       Impact factor: 2.967

7.  Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.

Authors:  Sajjad Khan; Silke Cameron; Martina Blaschke; Federico Moriconi; Naila Naz; Ahmad Amanzada; Giuliano Ramadori; Ihtzaz Ahmed Malik
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

8.  Keratin promoter based gene manipulation in the murine conducting airway.

Authors:  Stephen P Malkoski; Timothy G Cleaver; Shi-Long Lu; Jessyka G Lighthall; Xiao-Jing Wang
Journal:  Int J Biol Sci       Date:  2010-01-20       Impact factor: 6.580

9.  The Synergistic Effect of Conditional Pten Loss and Oncogenic K-ras Mutation on Endometrial Cancer Development Occurs via Decreased Progesterone Receptor Action.

Authors:  Tae Hoon Kim; Jinrong Wang; Kevin Y Lee; Heather L Franco; Russell R Broaddus; John P Lydon; Jae-Wook Jeong; Francesco J Demayo
Journal:  J Oncol       Date:  2009-10-27       Impact factor: 4.375

10.  Ovarian cancer mouse models: a summary of current models and their limitations.

Authors:  Miranda Y Fong; Sham S Kakar
Journal:  J Ovarian Res       Date:  2009-09-28       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.